CytoDyn, Inc. (CYDY)
0.3459
-0.01
(-1.93%)
USD |
OTCM |
May 19, 15:58
CytoDyn Shareholders Equity (Quarterly) : -104.29M for Feb. 28, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.248B |
| Alnylam Pharmaceuticals, Inc. | 1.075B |
| Amgen, Inc. | 9.19B |
| Savara, Inc. | 176.04M |
| Biogen, Inc. | 18.65B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 18.50M |
| Total Liabilities (Quarterly) | 122.78M |
| Debt to Equity Ratio | -0.2611 |
| Current Ratio | 0.3656 |
| Net Debt Paydown Yield | 0.09% |